A randomized controlled trial of intravenous versus oral cyclophosphamide in steroid-resistant nephrotic syndrome in children

Indian Journal of Nephrology

Volumn 27, Issue 6, 2017, Pages 430-434

  Shah, K M ^a   Ohri, A J ^a   Ali, U S ^a  

^a B J WADIA HOSPITAL FOR CHILDREN   (India)

Author keywords

Children; cyclophosphamide; India; steroid resistant nephrotic syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ALOPECIA; ARTICLE; BACTERIAL PERITONITIS; CELLULITIS; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPOALBUMINEMIA; INFECTION; KIDNEY BIOPSY; LEUKOPENIA; MALE; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; REMISSION; VOMITING;

EID: 85034631359     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/ijn.IJN_201_16     Document Type: Article

References (12)

1. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 1981;98:561-4.
2. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997;8:769-76.
3. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 1996;10:590-3.
4. Rennert WP, Kala UK, Jacobs D, Goetsch S, Verhaart S. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis. Pediatr Nephrol 1999;13:113-6.
5. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediatr Nephrol 2003;18:351-6.
6. Elhence R, Gulati S, Kher V, Gupta A, Sharma RK. Intravenous pulse cyclophosphamide-A new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol 1994;8:1-3.
7. Mantan M, Sriram CS, Hari P, Dinda A, Bagga A. Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome. Pediatr Nephrol 2008;23:1495-502.
8. Gulati S, Kher V. Intravenous pulse cyclophosphamide-A new regime for steroid resistant focal segmental glomerulosclerosis. Indian Pediatr 2000;37:141-8.
9. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children. Lancet 1974;2:423-7.
10. Bhimma R, Adhikari M, Asharam K. Steroid-resistant nephrotic syndrome: The influence of race on cyclophosphamide sensitivity. Pediatr Nephrol 2006;21:1847-53.
11. Chua A, Yorgin P. Steroid-resistant nephrotic syndrome. In: Molony DA, Craig JC, editors. Evidence-Based Nephrology. West Sussex: Wiley-Blackwell; 2009. p. 787-805.
12. Adhikari M, Bhimma R, Coovadia HM. Intensive pulse therapies for focal glomerulosclerosis in South African children. Pediatr Nephrol 1997;11:423-8.